1.850EUR+1.09%Mkt Cap: 23.33M EURP/E: —Last update: 2026-06-01
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the are…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap23.33M EUR
Enterprise Value15.79M EUR
Revenue (TTM)5.17M EUR
Gross Profit2.95M EUR
Net Income (TTM)-2.05M EUR
Revenue/Share0.4100 EUR
Last Price1.850 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees20
CountryDE
SectorHealthcare
IndustryDiagnostics & Research
ISINDE0006577109
Valuation
P/E (Trailing)—
P/E (Forward)-45.75
PEG—
EV/EBITDA-6.96
EV/Revenue3.06
P/S4.47
P/B0.62
EPS (TTM)-0.14
EPS (Forward)-0.04
52W Range
1.31067% of range2.120
52W High2.120 EUR
52W Low1.310 EUR
Profitability
Gross Margin63.38%
Oper. Margin-38.37%
EBITDA Margin-43.91%
Profit Margin-44.02%
ROE-5.36%
ROA-5.24%
Growth
Revenue Growth37.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF9.86M EUR
CapEx (TTM)402.60K EUR
FCF Margin—
FCF Yield—
Net Debt-7.29M EUR
Net Debt/EBITDA3.21
Balance Sheet
Debt/Equity—
Current Ratio31.90
Quick Ratio24.56
Book Value/Sh2.957 EUR
Cash/Share0.5780 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJun 16, 2023
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.400 EUR
Target Range4.300 EUR – 4.500 EUR
# Analysts2
Ownership
Shares Out.12.61M
Float—
Insiders2.00%
Institutions10.05%
Technical
SMA 501.510 (+22.6%)
SMA 2001.589 (+16.4%)
Beta0.42
S&P 52W Chg27.70%
Avg Vol (30d)11.47K
Avg Vol (10d)17.94K
Technical Indicators
RSI (14)82.0
MACD0.0699
MACD Signal0.0420
MACD Hist.+0.0280
BB Upper1.799 EUR
BB Middle1.587 EUR
BB Lower1.376 EUR
BB Width26.69%
ATR (14)0.0842 EUR
Vol Ratio (20d)3.27x